Genomic organization and alternative splicing of the human and mouse RPTPρ genes by Besco, Julie A. et al.
BMC Genomics (2001) 2:1 http://www.biomedcentral.com/1471-2164/2/1BMC Genomics (2001) 2:1Research article
Genomic organization and alternative splicing of the human and 
mouse RPTPρ genes
Julie A Besco1, Adrienne Frostholm1, Magdalena C Popesco1, 
Arthur HM Burghes2 and Andrej Rotter*1
Address:  1Departments of Pharmacology and and 2Molecular and Cellular Biochemistry The Ohio State University Columbus, OH 43210, USA
E-mail: Julie A Besco - besco.1@osu.edu; Adrienne Frostholm - frostholm.1@osu.edu; Magdalena C Popesco - popesco.1@osu.edu; 
Arthur HM Burghes - burghes.1@osu.edu; Andrej Rotter* - rotter.1@osu.edu
*Corresponding author
Abstract
Background:  Receptor protein tyrosine phosphatase rho (RPTPρ, gene symbol PTPRT) is a
member of the type IIB RPTP family. These transmembrane molecules have been linked to signal
transduction, cell adhesion and neurite extension. The extracellular segment contains MAM, Ig-like
and fibronectin type III domains, and the intracellular segment contains two phosphatase domains.
The human RPTPρ gene is located on chromosome 20q12-13.1, and the mouse gene is located on
a syntenic region of chromosome 2. RPTPρ expression is restricted to the central nervous system.
Results:  The cloning of the mouse cDNA, identification of alternatively spliced exons, detection
of an 8 kb 3'-UTR, and the genomic organization of human and mouse RPTPρ genes are described.
The two genes are comprised of at least 33 exons. Both RPTPρ genes span over 1 Mbp and are the
largest RPTP genes characterized. Exons encoding the extracellular segment through the
intracellular juxtamembrane 'wedge' region are widely spaced, with introns ranging from 9.7 to
303.7 kb. In contrast, exons encoding the two phosphatase domains are more tightly clustered,
with 15 exons spanning ∼ 60 kb, and introns ranging in size from 0.6 kb to 13.1 kb. Phase 0 introns
predominate in the intracellular, and phase 1 in the extracellular segment.
Conclusions:  We report the first genomic characterization of a RPTP type IIB gene. Alternatively
spliced variants may result in different RPTPρ isoforms. Our findings suggest that RPTPρ
extracellular and intracellular segments originated as separate modular proteins that fused into a
single transmembrane molecule during a later evolutionary period.
Background
Protein tyrosine phosphorylation regulates many impor-
tant cellular functions including signal transduction,
growth, differentiation, cell adhesion and axon guidance.
The balance between protein tyrosine kinase and phos-
phatase activity is an integral part of this regulatory
mechanism. A large number of protein tyrosine phos-
phatases have been identified, which fall into the broad
categories of cytoplasmic and receptor-like molecules.
All receptor-like protein tyrosine phosphatases (RPTPs)
contain an extracellular region, a single transmembrane
segment and at least one intracellular catalytic domain.
They have been subdivided into several classes based on
the structure of their extracellular segments (Figure 1). A
combination of immunoglobulin-like (Ig) domains and
fibronectin type III (FN-III) repeats in the ectodomain
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of type II RPTPs is a potential proteolytic cleavage site
within the membrane-proximal FN-III repeat. Upon
cleavage, extracellular N-terminal and predominantly
intracellular, membrane bound C-terminal segments are
generated, which remain non-covalently associated [1] A
subset of the type II class, identified previously as type
IIB RPTPs [2], is characterized by the presence of an N-
terminal MAM domain.
Currently, four type IIB phosphatases (PTPµ, PTPκ,
PCP-2 and RPTPρ) have been reported. The hPCP-2 [3],
hPTPκ [4], and hPTPµ [5] RPTPs are located on human
chromosomes 1, 6 and 18, respectively, and hRPTPρ is
located on chromosome 20 [6]. Several additional hu-
man RPTPs (PTPπ, PTPψ, hPTP-J, PTPRO) share very
high sequence similarity (>98%) with PCP-2, and are
likely to represent the same gene (Unigene database,
[http://www.ncbi.nlm.nih.gov/unigene] ). There are, in
addition, several murine homologues of the four human
genes: mPTPκ (Genbank #NM 008983), mPTPµ
(#NM008984), mRPTPρ (#AF152556), mRPTPρ -1 and
mRPTPρ -2 (# AF162856/7), mRPTPmam4 (#NM
021464), mPTPf (#D88187) and mPTPλ (#U55057). The
latter two are likely to be murine homologues of hPCP-2,
and mRPTPmam4 is the same gene as mRPTPρ.
RPTPρ is the most recently isolated member of the IIB
family [6, 7]. Northern blot and in situ hybridization
studies have shown that RPTPρ is largely restricted to
the central nervous system [6]. Within the CNS, expres-
sion is developmentally regulated and, in the mouse, de-
lineates a unique boundary region in the granule cell
layer of the cerebellar cortex [7]. Motifs in the RPTPρ ex-
tracellular segment (MAM, Ig and FN-III domains) are
commonly found in cell adhesion molecules. The two
phosphatase domains in the intracellular segment sug-
gest that RPTPρ, like other members of the RPTP family,
is involved in signal transduction through protein tyro-
sine dephosphorylation.
The human RPTPρ gene has been mapped to chromo-
some 20q12-13.1 [6]; it is located between anchor mark-
ers D20S99 and D20S96, and is flanked by the
phospholipase C gamma 1 and splicing factor SRp55-2
genes. The mouse gene maps to a syntenic region at 93
cM on mouse chromosome 2, a region closely linked to
Pltp and flanked by the markers, D2Mit22 and D2Mit52.
To date, only portions of the human RPTPκ, RPTPµ and
PCP-2 genes have been sequenced, however, the region
encompassing the human RPTPρ gene has been se-
quenced in its entirety (Chromosome 20 sequencing
group, Sanger Centre), but it is not, as yet, fully assem-
bled and annotated. The mouse chromosomal region
containing the RPTPρ gene has been sequenced (Celera
Discovery System), but it is also largely unassembled. In
this report, we describe the cloning of the mouse cDNA,
the identification of an unusually long 3' UTR, the iden-
tification of alternatively spliced exons, and the genomic
organization of the human and mouse RPTPρ genes.
Results and Discussion
The nucleotide sequence and domain structure of human 
RPTPρ
The nucleotide sequence of hRPTPρ cDNA predicts a
1463AA polypeptide containing at least eight domains.
The polypeptide is comprised of extracellular and intrac-
ellular segments. The extracellular segment contains a
signal peptide (AA 1-25), a MAM (meprin, A5 (neuropi-
lin), RPTPmu) domain (AA 32-191), an Ig-like domain
(AA 210-266) and four FN-III repeats (AA 286-369, 382-
471, 483-576 and 593-675). A potential proteolytic cleav-
Figure 1
Domain structure of the receptor-like protein tyrosine
phosphatase family. Variations in the extracellular domain
structure separate the RPTP family of transmembrane pro-
teins into five major classes (I-V). RPTPρ is a member of the
type IIB subfamily of RPTPs that includes RPTPκ, µ and PCP-
2.
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Columns (left to right): Exon number, protein domain, exon size, exon/intron junctional sequences, and intron phases are
shown. Amino acids (standard one-letter code) are listed below the coding nucleotides. D1 and D2 represent the first and sec-
ond phosphatase domains, respectively. a - i designations indicates the individual exons within a single domain; ** intron size is
not determined due to lack of contiguity of clones.
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tin repeat. The transmembrane segment is located at AA
765-785. The intracellular region contains a juxtamem-
brane 'wedge' region (AA 888-920), and two highly con-
served phosphatase domains (AA 1061-1162 and 1351-
1456). The 11 hallmark amino acids that define the cata-
lytic core of the first phosphatase domain are located at
AA 1104-1114. The stop codon is found after residue 1463
of the amino acid sequence.
Human RPTPρ genomic organization
We have determined that the region encompassing hu-
man RPTPρ is contained within 10 contiguous PAC
clones and 1 BAC clone (dJ269M15, dJ47A22, dJ753D4,
dJ914M10, bA32G22, dJ232N11, dJ3E5, dJ230I19,
dJ81G23, dJ707K17, and dJ1121H13; Sanger Center,
chromosome 20 group) (Figure 2). We have ordered
these clones by identifying RPTPρ exons within each of
them. The RPTPρ gene spans a minimum of 1 Mbp, and
the RPTPρ coding sequence is comprised of at least 33
exons, several of which are alternatively spliced. A prom-
inent feature of the RPTPρ gene structure is the consid-
erable variability of exon spacing (Figure 2). Exons 1-19
extend over the initial ∼ 1000 kbp of the gene; exons 1-10
are widely separated, while exons 10-19 are more closely
spaced. Of particular note are introns 1 and 7, which are
∼ 300 and ∼ 200 kbp long, respectively, considerably
longer than the next largest intron. In contrast, exons
20-28 and 29-32 form two tight clusters, which together
span approximately 60 kbp. In general, this pattern of
exon organization appears to be characteristic of most
RPTPs, as it is also observed in RPTPγ [8], LAR [9],
CD45 [10] and RPTPα [11]. Each of these phosphatases
has at least one very large intron in the 5'-region of the
gene. This feature is not restricted to receptor-like phos-
phatases as it is also present in a number of adhesion re-
ceptor genes, including E-cadherin, N-cadherin, P-
cadherin, N-CAM, deleted in colorectal cancer (DCC),
axonin-1 and F11 (discussed in [12]).
The exon and intron sizes and exon/intron junctional se-
quences of the human RPTPρ gene are detailed in Table
6. The majority of 5' and 3' splice sites are consensus se-
quences. There is some variation in the length of exons,
which range from 30 to 297 bp. Approximately one third
of the exons are less than 100 bp, while the remaining
two thirds are in the 100-300 bp range. Greater variation
occurs in the size of the introns, which range from 725 to
303,715 bp. The largest number of introns (15) falls into
the 104 to 105 bp bin, and somewhat fewer (12) fall into
the 103 to 104 bp bin size. Only 5 introns lie outside this
range: Three of these fall into the 102 to 103 bp range,
and two unusually long introns in the extracellular do-
main are over 105 bp.
The RPTP extracellular segment is comprised of protein
domains; the borders of these modules correspond to the
boundaries of exon-clusters. There are three possible
junctional phases between exons and introns: Phase 0
refers to introns with junctions between the triplet co-
dons, whereas phase 1 and 2 introns separate within the
triplet after the first and second nucleotides, respective-
ly. Figure 3A shows the distribution of intron phases rel-
ative to the domain structure of RPTPρ. Within the
RPTPρ gene, the number of phase 0 and phase 1 introns
is comparable at 15 and 12, respectively. In contrast,
there are only five phase 2 introns in the entire gene. A
notable feature of RPTPρ gene structure is that phase 1
introns appear to be preferentially associated with the
extracellular segment, where they flank each of the pro-
tein domain exon modules. The intracellular segment is
almost devoid of phase 1 introns. In contrast, phase 0 in-
trons are primarily associated with the intracellular seg-
ment, and are only infrequently represented in the
extracellular region.
Recently, RPTPs have been examined in sponges [13, 14]
the phylogenetically oldest extant metazoan. Although
sponges are multicellular organisms, they lack the cellu-
lar cohesiveness of the higher eukaryotes. When RPTPs
from yeast, sponge and human were aligned and rooted
cladograms constructed, the common early ancestor of
the phosphatase domains appeared to be yeast. The sec-
ond phosphatase domain arose as a duplication of the
first [13]. The RPTP extracellular domain was acquired
during the transition from single-celled to multicellular
organisms. In RPTPρ, the extracellular and intracellular
exon modules are separated by phase 1 and phase 0 in-
trons, respectively. Furthermore, intracellular introns
are much smaller than those in the extracellular seg-
ment. Together, these observations suggest that the RP-
TPρ extracellular and intracellular segments originated
Figure 2
Genomic organization of the human RPTP ρ gene. Exons
are shown as vertical bars and introns as thin horizontal
lines. Thicker horizontal lines represent PAC (dJ) and BAC
(b) clones (Sanger Centre, Chromosome 20 group) contain-
ing the RPTPρ gene, which extends over 1000 kbp of DNA
(figure not to scale).
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fling and duplication, respectively [13, 15]. The two seg-
ments became linked to form a functional
transmembrane molecule during the transition from sin-
gle to multicellular organisms.
Over fifty percent of the human genome is comprised of
repeat sequences [16], making it the first repeat-rich ge-
nome to be sequenced. Analysis of these numerous seg-
ments can provide important indications of the
evolutionary history of a particular region, or gene.
Transposon-derived elements form the largest category
of repeats, and include LINEs, SINEs, LTRs and DNA el-
ements. In the RPTPρ gene, the most common of these
are: LINE1 (7.6%) and LINE2 (2.0%); the SINEs Alu
(4.2%), MIR (3.6%) and THE (0.65%); LTR (0.7%); and
the DNA elements MLT (2.5%), MER (2.5%), and MST
(0.5%). Less common elements found in the RPTPρ gene
include Tiggers in introns 2, 7 and 9 (0.5%), HAL in in-
trons 2 and 7 (0.28%), MAD in introns 1 and 16
(0.013%), and U2 in intron 2 (0.006%). There is also a
Charlie repeat in intron 7 (0.005%). In addition to the
transposon-derived repeats, there is a pseudogene in in-
tron 7, a tRNA-derived repeat in intron 30, and 133 var-
iable length nucleotide tandem repeats (VNTRs/
microsatellites) found in the gene. The G/C content of
the RPTPρ gene is approximately 42%. Descriptions of
the above repeat elements may be found on Repbase at
[http://www.girinst.org./] 
The overall percentage of the RPTPρ gene comprised of
repeat sequences is lower (by 45%) than that of the entire
human genome. In the human genome, LINEs comprise
21% of repetitive sequences, SINEs 13%, LTRs 8%, and
DNA elements 3% [16]. In RPTPρ, LINEs comprise 9.6%
of repetitive sequences, SINEs 8.4%; LTRs 0.7%; and
DNA elements 6.3%. The significance of this deviation in
RPTPρ from the normal range is unknown.
cDNA cloning and genomic structure of mouse RPTPρ
The mouse RPTPρ cDNA was cloned using a combina-
tion of PCR and 5'-RACE. The mouse cDNA (Genbank
accession #AF152556) encodes a 1451AA polypeptide
that is 96% identical to that of the human protein and
Figure 3
A. Relationship between RPTPρ protein domains, corresponding exons and associated intron phases. Downward
arrows indicate intron phases. Protein domains (center) show good correspondence with exon boundaries (bottom line). B.
Percentage nucleotide identity between human and mouse exons. The percentage identity between human and mouse
exons was calculated by dividing the number of mismatched nucleotides by the total length of the exon. AS, alternative splice
site; FN-III, fibronectin type III repeats; Ig, immunoglobulin-like domain; MAM, meprin/A5/µ domain; PC, proteolytic cleavage
site; PTPase I and II, protein tyrosine phosphatase domains; TM, transmembrane domain.
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Columns (left to right): Exon number, protein domain, exon size, exon/intron junctional sequences, and intron phases are
shown. Amino acids (standard one-letter code) are listed below the coding nucleotides. D1 and D2 represent the first and sec-
ond phosphatase domains, respectively. a - i designations indicates the individual exons within a single domain; ** intron size is
not determined due to lack of contiguity of clones.
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Celera Discovery System mouse genomic database was
used to identify clones containing RPTPρ exons. These
clones were then ordered and analyzed to identify exon/
intron junctions. Exon and intron sizes, exon/intron
junctional sequences, and intron phases of the mouse
RPTPρ gene are shown in Table 7. In general, the exon/
intron splice sites in the mRPTPρ correspond to expect-
ed GT-AG intron consensus splicing sequences, and the
intron phases in mouse (Table 7) are identical to those in
the human gene (Table 6). Although the two species
share approximately 89% nucleotide identity overall,
when examined exon by exon, the degree of identity var-
ies slightly between the extracellular and intracellular
segments (Figure 3B). The overall identity of the mouse
and human extracellular and intracellular segments is
89% and 92%, respectively. In general, there is slightly
greater variance between the two species in the extracel-
lular segment; for example, mouse and human exons 1
and 9 share 78% and 95% identity. Within the intracellu-
lar segment, mouse exon 21 is 86% identical to that of the
human, and exon 24, which contains the first half of the
catalytic core, is 96% identical. Notably, the alternatively
spliced exons 14, 16 and 22a (discussed below) are 100%,
97% and 95% identical, respectively, indicating a high
degree of conservation between mouse and human. In
summary, the mouse and human genes are virtually
identical in terms of the number and size of exons, and
the exons differ only slightly with respect to the nucle-
otide sequence.
Exon/intron organization of the RPTPρ extracellular seg-
ment
MAM domain
The relationship between RPTPρ exon organization and
protein domain boundaries is shown in Figure 3A and in
Tables 6 and 7. Within the extracellular segment, exon 1
encodes the signal peptide, and exons 2, 3 and 4 encode
the single N-terminal MAM domain, a distinguishing
feature of all type IIB phosphatases. Although the func-
tion of the RPTPρ MAM domain is unclear, other type
IIB phosphatases have shown homophilic binding prop-
erties: When heterologously expressed in non-adherent
cells, both RPTPµ and RPTPκ bind homophilically to in-
duce the formation of large, calcium-independent aggre-
gates [17, 18]. Furthermore, when the RPTPµ MAM
domain was deleted, aggregation was eliminated [19],
implying that the domain had a crucial role in homophil-
ic cellular interactions.
The three RPTPρ MAM exons differ widely in size: 126
bp (exon 2), 272 bp (exon 3) and 82 bp (exon 4). All
MAM-associated introns are in phase 1, with the excep-
tion of the second internal intron, which is in phase 0.
MAM domains have been identified in a variety of cell
adhesion molecules. We have determined the exon struc-
ture of the MAM domain in all four human RPTP IIB
genes, and in human zonadhesin and human enter-
opeptidase (NCBI database). The genomic organization
of the MAM domain in all four IIB phosphatases is iden-
tical. In all RPTP IIB proteins (Genbank #NM 002844;
NM 002845; NM 005704; NM 007050) and in human
zonadhesin (Genbank #AF312032) there is a MAM do-
main at the N-terminus, the genomic structure of which
is highly conserved. In zonadhesin, there are two addi-
tional and adjacent MAM domains. The genomic organ-
ization of the latter two domains differs from that of the
first. The single MAM domain in the human enteropepti-
dase gene (Genbank #Y19124) is more internally located
than that of RPTPρ, close to the transmembrane region.
It is comprised of four exons that are 150, 135, 89 and 125
bp in length, and is unlike any of the IIB and zonadhesin
MAM domains. In summary, all known MAM domains
are located within the extracellular segment, but within
this region, their location, exon number and exon size
can vary considerably. The size and structure of exons
comprising the most N-terminal MAM domain appear to
be unique. Because the nucleotide sequence of the RPT-
Pρ MAM domain predicts a protein similar to that found
in the other type IIB RPTPs, it might be expected that the
RPTPρ MAM domain also participates in homophilic in-
teractions, as was shown for RPTPµ [19].
Ig domain
Adjacent to the MAM domain, the single Ig-like domain
is split into two similarly sized exons (5 and 6) by one in-
tron in phase 0 (Figure 3A). Introns flanking the Ig-like
domain are in phase 1. In the majority of genes encoding
Ig-like domains, only one exon encodes each domain,
while in others such as N-CAM, two exons encode each
domain [20]. The single Ig-like domain of the RPTPρ
gene falls into the latter category, suggesting a closer re-
lationship to N-CAM-like molecules. LAR has character-
istics of both groups [9], a feature which it shares with
several other genes, such as perlecan [21] and DCC [22].
Within the RPTP IIB family, the Ig-like domain appears
to act in conjunction with the MAM domain to bring
about homophilic cell-cell interactions [23].
FN-III domains
Following the Ig domain are four FN-III repeats (Figure
3A), each of which begins with a highly conserved proline
residue. FN-III domains are found in a wide range of
proteins, and recently, have been shown to be involved in
retinal axon target selection [24]. As a general rule, FN-
III domains are encoded either by 1 or 2 exons [25].
Within genes that encode multiple FN-III domains, exon
organization may be of one type, or a combination of the
two types. For example, N-CAM has 2 exons for each FN-
III domain [26], whereas tenascin [27] and LAR [9] have
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good correlation between exon structure and FN-III
boundaries (Figure 3A), although there is some variation
in the number of exons per domain: Each of the first two
FN-III repeats is encoded by a single exon (exons 7 and
8, respectively). In contrast, the third FN-III repeat is en-
coded by two exons (9 and 10). Somewhat atypically, the
fourth FN III repeat is encoded by three exons (11, 12 and
13). This domain contains a putative proteolytic cleavage
site. RPTPρ FN-III repeats share high sequence similar-
ity with those of N-CAM, but only the third FN-III do-
main in RPTPρ is encoded by two exons. In contrast to
the type IIA phosphatase LAR, the RPTPρ gene does not
contain exons encoding more than one fibronectin do-
main; however, like LAR, it has a FN-III domain encoded
by three exons.
In the majority of known cases, the exon/intron junc-
tions corresponding to the FN-III domain boundaries
are in phase 1. When two exons encode a FN-III domain,
an intron interrupts the coding region in a central, rela-
tively non-conserved, part of the domain, and the exon/
intron junction may be in any phase. In the RPTPρ gene,
introns separating the individual FN-III repeats are in
phase 1; the intron internal to the third repeat is in phase
0, and introns internal to the fourth FN-III repeat are in
phase 2 and 0, respectively.
Exon/intron organization of the RPTPρ intracellular seg-
ment
Juxtamembrane region
Following the transmembrane segment (exon 15), exons
16-18 encode the juxtamembrane region (Figure 3A, Ta-
bles 6 and 7). This segment of the RPTPρ protein is sim-
ilar to the membrane proximal region in the type IV
phosphatase, murine RPTPα, for which the crystal struc-
ture has been determined [28]. RPTPα exists as a dimer
in which the catalytic site of one molecule is blocked by
contact with a 'wedge' from the other. Specifically, the
'turn' part of the helix-turn-helix motif is inserted into
the active site, which maintains the WpD loop in the
open state [28]. In other phosphatases [29], the WpD
loop undergoes a conformational shift upon substrate
binding, which appears to be crucial for catalysis. Thus,
it is very likely that the dimeric form of RPTPα is unable
to bind tyrosine-phosphorylated substrates, rendering it
catalytically inactive. The negative charge of two adja-
cent residues within a highly conserved sequence in the
juxtamembrane region appears to be crucial for inhibi-
tion [28, 30]. In RPTPα, these two residues are negative-
ly charged aspartates. In type IIB RPTPs, the first residue
is changed to an alanine in PCP-2 and RPTPµ, and to a
serine in RPTPκ . The second residue is retained as either
a glutamate in PCP-2 and RPTPµ, or an aspartate in RP-
TPκ . These single amino acid changes may indicate a
somewhat weaker level of inhibition. This is supported
by the examination of the crystal structure of RPTPµ,
which shows that although a wedge is formed, catalytic
activity is not inhibited by its insertion into the active site
on the adjacent monomer [31]. However, in the case of
RPTPρ, the first residue is a glycine, and the second is the
large basic residue, glutamine. Thus, the RPTPρ juxtam-
embrane catalytic region is likely to have a different con-
formation to that of the other phosphatases and a net
positive charge, making the regulation of phosphatase
activity by dimerization-induced wedge inhibition un-
likely.
Phosphatase domains
Although the extracellular regions of receptor-like phos-
phatases are highly variable, the intracellular tandem
phosphatase domains appear quite closely related. The
structure of the CD45 gene indicates that both protein ty-
rosine phosphatase (PTPase) domains have a very simi-
lar exon/intron organization, which probably arose by
duplication [10]. In RPTPρ, the first and second phos-
phatase domains are encoded by exons 19-26 and 27-32,
respectively (Figure 3A). The exon structure of the RPT-
Pρ phosphatase domains, and that of homologous do-
mains in PCP-2 (NM_005704), RPTPκ (NM 002844),
RPTPµ (NM 002845), LAR [9], CD45 [10] RPTPα [11],
RPTPγ [8] and rat Esp/mOST-PTP [32, 33], are com-
pared in Figure 4. We have deduced the genomic struc-
ture of RPTPκ, RPTPµ and PCP-2 by comparing known
cDNA sequences with human genomic clones (NCBI).
The positions of the exon boundaries in the phosphatase
domains of RPTPρ, RPTPκ, RPTPµ and PCP-2 coincide
exactly, and correspond well with the five other phos-
phatases. LAR is somewhat anomalous in that, although
the exon/intron structure of the second phosphatase do-
main is generally similar to that of the other RPTPs, ex-
ons in the first phosphatase domain are fewer in number,
but greater in size. The final exon in all nine genes en-
codes the end of the second phosphatase domain, the
short C-terminus and the entire 3'-untranslated region.
A striking similarity among the RPTP genes is the con-
servation of exon/intron junction 24/25 in the first phos-
phatase domain. In LAR, CD45 and RPTPα, this junction
interrupts the highly conserved sequence VHCSAGV,
part of the catalytic core of the phosphatase [34, 35]. Al-
though this exon/intron junction in the IIB phos-
phatases corresponds exactly, there is a change in the
last amino acid from a valine to an alanine. Interestingly,
an exon/intron junction is not observed at this position
in the cytoplasmic PTPase PTP1B [36], an observation
that may indicate an early evolutionary divergence of the
cytoplasmic and transmembrane PTPases [37].
BMC Genomics (2001) 2:1 http://www.biomedcentral.com/1471-2164/2/1Although the exon/intron structure of the two phos-
phatase domains was remarkably similar in each of the
nine RPTPs examined, there were variations in exon size
and number, primarily in those close to the transmem-
brane domain. For example, the third exon (135 nt) in
the first phosphatase domain of rat Esp/mOST-PTP and
RPTPγ is replaced by two smaller exons (37 and 98 nt) in
RPTPα, CD45, RPTPρ, PCP-2, RPTPκ, and RPTPµ . Two
smaller exons replace a single exon at the C-terminal end
of the first phosphatase domain of rat Esp/mOST-PTP.
Similarly, at the start of the second phosphatase domain,
the first exon (174nt) in RPTPρ, PCP-2, RPTPκ, RPTPµ
and LAR is replaced by two smaller exons in rat Esp/
mOST-PTP, RPTPα, RPTPγ and CD45. In each case, the
total number of nucleotides in the two smaller exons is
virtually identical to that of the single larger exon at the
same position. It is unclear whether these changes in
exon number resulted from intron gain or exon fusion.
RPTPρ 3' untranslated region
Following the second phosphatase domain, there is a
long (8.0 kb) 3' untranslated sequence. BLAST compari-
sons identified a region on the KIAA0283 gene (Genbank
accession #AB006621) that showed 99% identity to nu-
cleotides 3181 to 4437 of the hRPTPρ sequence. Thus,
the 3'-UTR of hRPTPρ, which is contained in exon 32,
was identified as KIAA0283. Polyadenylation signals
were found at 12425 nt and 12663 nt (NM_007050).
Alternative splicing of mouse and human RPTPρ genes
Comparison of the four RPTP type IIB (RPTPµ, RPTPκ,
RPTPρ, PCP-2) nucleotide sequences predicted that, at
least, two exons (14 and 16) are likely to be alternatively
Figure 4
Genomic organization of the two phosphatase domains in nine RPTPs. Boxed numbers indicate the number of nucle-
otides in each exon; interconnecting horizontal lines represent introns (neither are to scale). Note that exon 22a is not shown
in order to preserve alignment among the type IIB RPTPs.
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850) in xenopus RPTPρ that is absent in the majority of
other type IIB RPTPs, raised the possibility of an alterna-
tively spliced exon between exons 17 and 18. Human fetal
brain, mouse neonatal brain, and several regions (cortex,
forebrain, brainstem, and cerebellum) of adult C57BL/6
mouse brain were examined for the presence of alterna-
tively spliced regions. PCR primers were designed to am-
plify the regions encapsulating exons 14 and 16, and the
region between exons 17 and 18. An additional region be-
tween exons 22 and 23 was also examined. The identity
of all PCR products was verified by sequencing.
The RPTPρ exon 14 primers yielded two products of 257
and 200 bp (Figure 5A and 5B), indicating a 57 nt alter-
natively spliced region at 2177 to 2233 nt. This 19AA seg-
ment is encoded by exon 14. Both splice forms were
observed in human fetal, and in neonatal and adult
mouse brain mRNA. We have obtained similar results
for RPTPµ (data not shown), in which exon 14 was re-
ported to be absent (NM_002845). The RPTPρ exon 16
primers yielded two bands of 356 and 326 bp (Figure 5C
and 5D). This indicates an additional 10 AA alternatively
spliced region, located between the transmembrane and
the first phosphatase domain (2370-2399 nt). Both tran-
scripts were present in mouse and human brain, and
were observed in all brain regions analyzed. PCR of the
same region in RPTPµ yielded only one product that did
not contain the exon 16 sequence (data not shown). A
third alternatively spliced exon (22a) was identified in
the first phosphatase domain between exons 22 and 23.
Exon 22a was inserted after nucleotide 3172 in mouse,
and after nucleotide 3232 in human RPTPρ, predicting
an additional alternatively spliced region 20 AA in
length. In each case, primers yielded two bands of 93 and
152 bp (Figure 5E and 5F) in all brain regions examined.
It remains to be determined if other members of the type
IIB subfamily also contain this exon, or whether the re-
gion is unique to RPTPρ.
Comparison of xenopus, mouse and human type IIB
RPTP nucleotide sequences indicated the possibility of a
fourth alternatively spliced region located 3' to exon 17,
within the wedge domain. This 75 nt segment is present
in the reported sequence of human RPTPµ (2445-2520
nt) and in xenopus RPTPρ (2448-2523 nt). It is absent in
the reported sequences of human and mouse RPTPκ,
RPTPρ and PCP-2. The exon 17/18 primers were de-
signed to amplify two potential products of 209 and 134
nt. However, only a single product of 134 nt was observed
in human and mouse brain regions (data not shown).
This sequence appears to be unique to human RPTPµ
and xenopus RPTPρ and is unlikely to represent an alter-
natively spliced exon in any of the RPTP IIB genes.
Both splice variants of exons 14, 16 and 22a were present
in human and mouse brain, at all ages and in all brain re-
gions examined. Although the RPTPρ protein products
encoded by the alternatively spliced exons do not appear
to encode any known motifs, different isoforms of the
phosphatase, with as yet unknown functions, are likely to
be present. Alternatively spliced isoforms of the related
RPTPs, LAR [38] and RPTPβ/ζ [39], are spatially and
temporally distinct in the central nervous system, and
there is evidence that alternatively spliced exons can in-
fluence ligand binding, as is the case with LAR [9].
Conclusions
We describe the cloning of the mouse RPTPρ cDNA, the
genomic structure and alternative splicing of the mouse
and human genes, and the presence of an 8 kb 3'-UTR in
human RPTPρ. RPTPρ is the largest RPTP gene charac-
terized to date, extending over more than 1 megabase
pairs of genomic DNA. Its considerable length is due,
primarily, to expanded introns in the extracellular re-
gion. The protein domains of the extracellular segment
are encoded by 1 to 3 exons, which form modules that are
flanked by phase 1 introns. The majority of introns in the
intracellular segment are in phase 0, and are relatively
small. These data suggest that the ectodomain and the
phosphatase domain arose separately by exon shuffling
and duplication and fused at a later evolutionary period.
The MAM domain, the region characterizing type IIB
phosphatases, possesses a unique genomic structure
common to all such domains when located at the N-ter-
minus. The fourth fibronectin repeat in RPTPρ is encod-
ed by three exons, an additional feature found only in
type II phosphatases. At least two alternatively spliced
exons flank the transmembrane domain, the region
showing the greatest variability between the four IIB
phosphatases. An additional alternatively spliced exon
precedes the catalytic core of the first phosphatase do-
main. Comparison of the genomic structure of represent-
ative members of the RPTP family (types I-V) indicates
that the intron/exon organization of both phosphatase
domains is highly conserved. There is considerable vari-
ation in the length of the 3' UTR in the RPTPs; at 8 kb,
the RPTPρ 3' UTR is the longest characterized to date.
Our results provide the first characterization of the ge-
nomic structure of an RPTP type IIB gene. This informa-
tion will facilitate future studies of promoter and other
regulatory elements responsible for the tissue specificity
of gene expression.
Materials and Methods
Cloning of mouse RPTPρ cDNA
The mouse RPTPρ cDNA was obtained using a combina-
tion of 5'-RACE and PCR by methods described in [40].
Total RNA was isolated (RNAzol, Tel-Test, Friendswood,
TX) from C57BL/6 mouse brain and used to synthesize
BMC Genomics (2001) 2:1 http://www.biomedcentral.com/1471-2164/2/1Figure 5
Alternative splicing of exons 14 and 16. RT-PCR products were amplified using primers flanking exon 14 (panels A and B),
exon 16 (panels C and D) and exon 22a (panels E and F). Left panels: bands in lanes 1, 2, and 3 are from human fetal brain,
mouse P1 brain, and mouse P60 brain total RNA, respectively. Right panels: bands in lanes 4, 5, 6 and 7 contain total RNA from
cerebellum, brain stem, basal forebrain and cortex (P23), respectively. Transcripts containing both splice forms of exons 14, 16
and 22a were found in all lanes.
BMC Genomics (2001) 2:1 http://www.biomedcentral.com/1471-2164/2/1first strand cDNA (AMV-RT, Roche Molecular Biochem-
icals, Indianapolis), which was then amplified by PCR
using degenerate primers based on the human RPTPρ
sequence. PCR products were analyzed on 1% agarose
gels and subcloned into the TOPO2.1 vector (Invitrogen,
Carlsbad, CA). Each strand was sequenced at least twice.
Sequence analysis and assembly were performed using
Vector NTI Suite (Informax, Bethesda, MD). Murine RP-
TPρ sequences were identified by BLAST [41] using
blastn, on the nr database, with all parameters set to de-
fault values. An initial 923 nt fragment was obtained,
which spanned the region from the 4th FN-III repeat
through the first phosphatase domain. Additional PCR
was performed using new gene specific primers based on
the newly isolated murine RPTPρ sequence (Genbank
#AF152556), and degenerate primers based on the hRP-
TPρ sequence (Genbank #NM 007050).
Alternative splicing
First strand cDNA was made from total RNA from hu-
man fetal brain (16-24 weeks; Clontech, Palo Alto, CA)
and from neonatal (P1) and adult (P60) mouse whole
brain using Superscript II Reverse Transcriptase (Gibco
BRL, Rockville, MD). In addition, cDNA was made from
cerebellum, brainstem, forebrain and cortex (P23). The
reverse primer, 5' CACGCACACAGTTGAAGATGTCC,
which is complementary to a region near the end of the
first phosphatase domain (3580 to 3602 nt;
NM_007050), was used in all cDNA synthesis. PCR was
performed (Expand Long Template PCR system, Roche
Molecular Biochemicals, Indianapolis) as recommended
by the manufacturer. Primers were as follows: Exon 14:
forward primer, 5' CAACTGTGTTCGTCTGGCTAC
(AS1); reverse primer, 5' GCCCAGGAGAATGATGAT-
GAAC (Ex15rv2). Exon 16: forward primer, 5'GAGAAG-
CAGGTGG ACAACACCGTG (AS2fw); reverse primer, 5'
GCTCATCTCCACAGGGTCAC (Exrv). Exon 17/18: for-
ward primer, 5' CGCA ATGATGAAGGCTTCTC (Exfw);
reverse primer, 5' GCTCATCTCCACAGGGTCAC
(Exrv).). Exon 22a: forward primer, 5' CTCTGCCAG-
CATCGTCATGGTCAC (Ex22fw); reverse primer, 5'
GTCTCCATAGACCTCTGTGTCATCTGGCC (Ex23rv).
All primers were used at a final concentration of 250 nM.
An Eppendorf Mastercycler Gradient was used with the
following cycling parameters: 2 minutes at 94°C, 35 cy-
cles of 15 seconds at 94°C, 30 seconds at 56°C (exon 14),
55°C (exon 16), 57°C (exon 17/18) or 60°C (exon22/23),
45 seconds at 72°C, and a final extension step (2 minutes
at 72°C). The PCR products were run on 4% NuSieve
GTG agarose (FMC, Rockville) gels and confirmed by se-
quencing.
Human and mouse nucleotide sequence analysis
The human RPTPρ cDNA sequence was used to search
the Sanger Center's chromosome 20 database for ge-
nomic clones encoding RPTPρ exons. The chromosomal
region containing the human RPTPρ gene was repre-
sented within PAC and BAC clones of chromosome 20,
contig 125. The mouse cDNA sequence (Genbank acces-
sion #AF152556) was used to search the Celera Discov-
ery System mouse genomic database for clones
containing RPTPρ exons.
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